[1]
|
Williams, C.H. (2014) Malignant Hyperthermia: A Runaway Thermogenic Futile Cycle at the Sodium Channel Level. Advances Bioscience Biotechnology, 5, 197-200. http://dx.doi.org/10.4236/abb.2014.53025
|
[2]
|
Britt, B.A. (1987) A History of Malignant Hyperthermia. In: Malignant, H., Ed., BA Britt, Martinus Nijhoff Publishing, Boston, xi-xxii.
|
[3]
|
Zukaitis, M.G., Hoech, Jr., G.P. and Robinson, J.D. (1986) Malignant Hyperthermia—Pre and Post Dantrolene: A Survey of the Greater Kansas City Area from 1965-1985: 15 Sept 1965. January 1986 Meeting of the Rocky Mountain Traumatoligic Society in Aspen,
|
[4]
|
Wallin, R.F. and Napoli, M.D. (1971) Sevoflurane (Fluro-methyl-1,1,1,3,3,3,-hexafluro-2-propyl ether) a New Inhalational Agent. Fed Proceed, 30, 442.
|
[5]
|
Williams, C.H., et al. (1989) Cardiac Performance and Hemodynamics in Malignant Hyperthermia Susceptible and Normal Pigs during Sevoflurane Anesthesia. Attachment #1.
|
[6]
|
Williams, C.H., Stovall, R.M., Dozier, S.E., Watts, M.T., Bayless, P.A., Marvasti, M.A., Farias, M., Ekery, D.D., Daley, I.W. and Satoh, N. (1988) Cardiac Performance and Hemodynamics in Malignant Hyperthermia Susceptible and Normal Pigs during Sevoflurane Anesthesia. Poster Presentation at the New York State Society of Anesthesiologists Meeting, Hilton, New York City, 10 December 1989,
|
[7]
|
Watts, M.T., Escarzaga, M. and Williams, C.H. (1992) GTas-Chromatographic Headspace Analysis of Sevoflurane. Journal of Chromatography B: Biomedical Sciences and Applications, 577, 289-298. http://dx.doi.org/10.1016/0378-4347(92)80250-T
|
[8]
|
Abbott Laboratories v. Baxter International Inc. (2002) WL 467147 (N.D.Ill. 2002).
|
[9]
|
Kharasch, E.D. (2007) Sevoflurane: The Challenges of Safe Formulation. APSF Newsletter Fall, 22, 48.
|
[10]
|
Rosenberg, H. and Rothstein, A. (2006) Malignant Hyperthermia Death Holds Many Lessons. APSF Newsletter: Summer, 21, 32-34.
|
[11]
|
Williams, C.H., et al. (1977) Proceedings of the Focus on Malignant Hyperthermia Symposium, Wausau, 13 September, 3 Chapters. EO Henschel, Appleton Century Crofts, New York.
|
[12]
|
Hoech, Jr., G.P., Roberts, J.T., Williams, C.H., Waldman, S.D., Simpson, S.T. and Trim, C.M. (1980) Prevention of Porcine Malignant Hyperthermia with Metocurine. In: Thermoregulatory Mechanisms and Their Therapeutic Implications. 4th International Symposium Pharmacology of Thermoregulation, Oxford, 137-141, Karger:Basel.
|
[13]
|
Buzello, W., Williams, C.H., Chandra, P., Watkins, M.L. and Dozier, S.E. (1985) Vecuronium and Porcine Malignant Hyperthermia. Anesthesia & Analgesia, 64, 575-279. http://dx.doi.org/10.1213/00000539-198505000-00012
|
[14]
|
Williams, C.H., Dozier, S.E., Ilias, W.K. and Fulfer, R.T. (1985) Porcine Malignant Hyperthermia: Testing of Atracurium in MH Susceptible Pigs. Anesthesia & Analgesia, 64, 112.
|
[15]
|
Williams, C.H., Chandra, P., Serda, R. and Martinez, M. (1992) Malignant Hyperthermia Induction in Susceptible Swine Following Exposure to Organon 9426. Abstracts S350. Anesthesia & Analgesia, 74, S1-S365.
|
[16]
|
(2006) MHAUS AMRA Report Version 9.1.
|
[17]
|
(2008) Milwaukee Journal Sentinel: JS Online: Only 20, Athlete Had Zest for Life (Steven Nook). By Amy Rabideau Silvers.
|
[18]
|
Stephanie Kuleba, Case # 080366, Palm Beach Medical Examiner’s Office.
|
[19]
|
(2008) The Informed Patient: A Fresh Focus on a Rare Risk of Anesthesia. The Wall Street Journal: 4/30/2008, Laura Landro.
|
[20]
|
Medical Examiner’s Office (2008) West Palm Beach, Stephanie J. Kulebea, Case # 080366:21 May 2008.
|
[21]
|
(2008) Making Everlasting Memories, Worldwide Memoralization—Stephanie Jude Kuleba: Guest Book: 10/24/2008.
|
[22]
|
Williams, C.H., Houchins, C. and Shanklin, M.D. (1975) Energy Metabolism in Pigs Susceptible to the Fulminant Hyperthermia-Stress Syndrome. British Medical Journal, 3, 411-413, Errata 604.
|
[23]
|
Cark, M.G., Williams, C.H., Pfeifer, W.F., Bloxham, D.P., Holland, P.C., Taylor, C.A. and Lardy, H.A. (1973) Accelerated Substrate Cycling of Fructose-6-Phosphate in the Muscle of Malignant Hyperthermic Pigs. Nature, 245, 99-101. http://dx.doi.org/10.1038/245099a0
|
[24]
|
Williams, C.H. (1974) The Development of an Animal Model for the Fulminant Hyperthermia-Porcine Stress Syndrome. Proceedings of the Focus on Malignant Hyperthermia Symposium, Wausau, 13 September 1974, 117-140.
|
[25]
|
Williams, C.H., et al. (1977) The Fulminant Hyperthermia-Stress Syndrome: Genetic Aspects, Hemodynamic and Metabolic Measurements in Susceptible and Normal Pigs. Proceedings of 2nd International Symposium on Malignant Hyperthermia, Denver, 1-3 April 1977, 161-173.
|
[26]
|
Williams, C.H., Farias, M., Marvasti, M.A., Knight, A.B., Ekery, D.D., Daley, I.W. and Zayed, I. (1990) Malignant Hyperthermia Induction in Susceptible Swine Following Exposure to Arduan. Anesthesia & Analgesia, 70, S433. http://dx.doi.org/10.1213/00000539-199002001-00433
|
[27]
|
Williams, C.H., et al. (1986) Metabolic Rate in Malignant Hyperthermia Pigs. In: Swine in Biomedical Research, Vol. 1, Ed., ME Tumbleson, Plenum, New York, 573-582.
|
[28]
|
Williams, C.H. (1988) Experimental Malignant Hyperthermia. Springer Verlag, New York.
|
[29]
|
Steiss, J.E., Bowen, J.M. and Williams, C.H. (1981) Electromyographic Evaluation of Malignant Hypermia Susceptible Pigs. American Journal of Veterinary Research, 42, 1175-1178.
|